Amber Feng

Most-cited papers

HDAC inhibitor suppresses proliferation and invasion of breast cancer cells through regulation of miR-200c targeting CRKL
Xue-hai Bian, Zhong-Xing Liang, Amber Feng, Eric Salgado +1 more
2017Biochemical Pharmacology51 citations Open access
Semantic Scholar
Overexpression of HDAC9 Promotes Invasion and Angiogenesis of Triple Negative Breast Cancer by regulating microRNA-206
Eric Salgado, Xue-hai Bian, Amber Feng, H. Shim +1 more
2018Biochemical and Biophysical Research Communications - BBRC47 citations Open access
Semantic Scholar
Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library
Renren Bai, Qi Shi, Zhong-Xing Liang, Y. Yoon +6 more
2016European journal of medicinal chemistry19 citations Open access
Semantic Scholar
Novel anti-inflammatory agents targeting CXCR4: Design, synthesis, biological evaluation and preliminary pharmacokinetic study
Renren Bai, Zhong-Xing Liang, Y. Yoon, Eric Salgado +3 more
2017European journal of medicinal chemistry16 citations Open access
Semantic Scholar
Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives
Renren Bai, Jian Sun, Zhong-Xing Liang, Y. Yoon +5 more
2018European journal of medicinal chemistry11 citations Open access
Semantic Scholar
MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer
Zhong-Xing Liang, Amber Feng, H. Shim
2020Cancer Chemotherapy and Pharmacology10 citations
Semantic Scholar
Development of CXCR4 modulators based on the lead compound RB-108
Renren Bai, Xiaokang Jie, Jian Sun, Zhong-Xing Liang +9 more
2019European journal of medicinal chemistry10 citations Open access
Semantic Scholar
Retraction Note to: MicroRNA‑30c‑regulated HDAC9 mediates chemoresistance of breast cancer
Zhong-Xing Liang, Amber Feng, H. Shim
2022Cancer Chemotherapy and Pharmacology0 citations Open access
Semantic Scholar